Structural and biochemical analysis of ATPase activity and EsxAB substrate binding of M. tuberculosis EccCb1 enzyme
Abstract
The EccC enzyme of M. tuberculosis ESX-1 system is a promising target for antivirulence drug development. The EccC enzyme comprises two polypeptides (i) EccCa1, a membrane bound enzyme having two ATPase domains D2 & D3 (ii) cytosolic EccCb, which contains two ATPase domains. In current study, we have analyzed the low-resolution structure of EccCb1, performed ATPase activity and EsxAB substrate binding analysis. The EccCb1 enzyme eluted as oligomer from size exclusion column and small angle X-ray scattering analysis revealed the double hexameric structure in solution. The EccCb1 enzyme showed catalytic efficiency (kcat/KM)[~] 0.020{+/-}0.005 M-1 min-1, however [~] 3.7 fold lower than its D2 and [~]1.7 fold lower than D3 domains respectively. The D2 and D3 domains exhibited the ATPase activity and mutation of residues involved in ATP+Mg2+ binding have yielded 56-94% reduction in catalytic efficiency for both D2 and D3 domains. The EccCb1 binds the EsxAB substrate with KD [~] 11.4{+/-}3.4 nM via specific groove located at C-terminal region of D3 domain. ATP binding to EccCb1 enhanced the EsxAB substrate binding by [~] 3 fold, indicating ATPase energy involvement in EsxAB substrate translocation. We modeled the dodecameric EccCb1+EsxAB+ ATP+Mg2+ complex, which showed the binding pockets involved in ATP+Mg2+ and EsxAB substrate binding. The enzyme dynamics involved in ATP+Mg2+ and EsxAB substrate recognition were identified and showed the enhanced stability of EccCb1 enzyme as a result of ligand binding. Overall, our structural and biochemical analysis showed the low-resolution structure and mechanism involved in ATPase activity and EsxAB substrate binding and dynamics involved in EsxAB substrate and ATP+Mg2+ recognition. Overall, our structural and biochemical data on EccCb1 will contribute significantly in development of antivirulence inhibitors, which will prevent virulence factor secretion by M. tuberculosis ESX-1 system.
02 /Specification & Classification
Click any tag to browse matching papers- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Identification of the novel inhibitors against M. tuberculosis ESX-1 secretion system EccA1 enzyme using virtual screening, docking and dynamics simulation techniques
Ramesh Kumar, Ajay Kumar Saxena·bioRxiv·Apr 14, 2026
- New insights into the domain of unknown function DUF of EccC5, the pivotal ATPase providing the secretion driving force to the ESX5 secretion system
F. Ceballos-Zuniga, M. Menendez, I. Perez-Dorado·bioRxiv·Jan 26, 2024
- Dissection of function and recognition mechanism of M. tuberculosis ESX-1 secreted virulence factor EspC
R. Sharma, V. K. Kashyap, … A. K. Saxena·bioRxiv·Sep 24, 2021
- Streptomycin and Pyridomycin drug molecules provide the most potential inhibitors against Rv3871 to cure Tuberculosis
S. Bhushan, Y. S. Raja, S. Mishra·bioRxiv·Jul 19, 2022
- Structural and molecular dynamics of Mycobacterium tuberculosis malic enzyme, a potential anti-TB drug target
K. H. Burley, B. J. Cuthbert, … C. W. Goulding·bioRxiv·Jul 7, 2020
- Crystallographic fragment binding studies of the Mycobacterium tuberculosis trifunctional enzyme suggest binding pockets for the tails of the acyl-CoA substrates at its active sites and a potential substrate channeling path between them
S. Dalwani, A. Metz, … R. Venkatesan·bioRxiv·Jan 11, 2024